{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:31:03Z","timestamp":1792092663457,"version":"4.4.0"},"reference-count":81,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100005849","name":"Baqiyatallah University of Medical Sciences, Tehran, Iran","doi-asserted-by":"publisher","award":["402000414"],"award-info":[{"award-number":["402000414"]}],"id":[{"id":"10.13039\/501100005849","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>The growing prevalence of drug-resistant infections and the constraints of existing\ncancer treatment have increased efforts to find new therapeutic agents. CM11 is a synthetic hybrid\npeptide derived from Cecropin and Melittin, which is a promising candidate because it has a broadspectrum\nof antimicrobial and anticancer effects. Preclinical research indicates that it has a rapid\nmechanism of action, interfering with bacterial membranes, preventing biofilm formation, and\ninducing apoptosis in various cancer cell lines, including leukemia and hepatocellular carcinoma.\nTo address the inherent limitations of peptide therapeutics, new formulations, such as chitosanbased\nnanoparticles, have been developed to increase the stability, targeted delivery, and\ntherapeutic efficacy of CM11. Moreover, CM11 exhibits synergistic activity with standard\nantibiotics or anticancer agents, thereby enabling lower effective dosages and reducing the\nchallenges of toxicity and resistance. Despite its potential, it faces translational challenges,\nincluding peptide stability, dose-dependent toxicity, immunogenicity, and limited clinical data.\nFurther peptide engineering, optimization of advanced delivery systems, and extensive clinical\ntrials will be needed to achieve successful translation of CM11 from bench to bedside. In\nconclusion, CM11 is a multifunctional and promising tool for the development of new, synergistic\nregimens against resistant infections and malignancies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298665449691260331114022","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:56:06Z","timestamp":1777550166000},"page":"409-421","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Comprehensive Review of the Antimicrobial Peptide CM11: Structure, Biological Properties, and Therapeutic Prospects"],"prefix":"10.2174","volume":"33","author":[{"given":"Roya","family":"Khalilifar","sequence":"first","affiliation":[{"name":"Department of Genetics, Faculty of Biology, North Tehran Branch, Islamic Azad University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sadegh","family":"Lotfi","sequence":"additional","affiliation":[{"name":"Nanobiotechnology Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences,Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozafar","family":"Mohammadi","sequence":"additional","affiliation":[{"name":"Applied Biotechnology Research Center, New Health Technologies Institute, Baqiyatallah University ofMedical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sadegh","family":"Hashemzadeh","sequence":"additional","affiliation":[{"name":"Nanobiotechnology Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences,Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"11864","DOI":"10.3390\/ijms241411864","volume":"24","author":"Bakare O.O.","year":"2023","unstructured":"Bakare O.O.; Gokul A.; Niekerk L.A.; Aina O.; Abiona A.; Barker A.M.; Basson G.; Nkomo M.; Otomo L.; Keyster M.; Klein A.; Recent progress in the characterization, synthesis, delivery procedures, treatment strategies, and precision of antimicrobial peptides. Int J Mol Sci  2023,24(14),11864","journal-title":"Int J Mol Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/415389a","volume":"415","author":"Zasloff M.","year":"2002","unstructured":"Zasloff M.; Antimicrobial peptides of multicellular organisms. Nature  2002,415(6870),389-395","journal-title":"Nature"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nbt1267","volume":"24","author":"Hancock R.E.W.","year":"2006","unstructured":"Hancock R.E.W.; Sahl H.G.; Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol  2006,24(12),1551-1557","journal-title":"Nat Biotechnol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1128\/CMR.00056-05","volume":"19","author":"Jenssen H.","year":"2006","unstructured":"Jenssen H.; Hamill P.; Hancock R.E.W.; Peptide antimicrobial agents. Clin Microbiol Rev  2006,19(3),491-511","journal-title":"Clin Microbiol Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.3390\/ijms25116030","volume":"25","author":"Kravchenko S.V.","year":"2024","unstructured":"Kravchenko S.V.; Domnin P.A.; Grishin S.Y.; Zakhareva A.P.; Zakharova A.A.; Mustaeva L.G.; Gorbunova E.Y.; Kobyakova M.I.; Surin A.K.; Poshvina D.V.; Fadeev R.S.; Azev V.N.; Ostroumova O.S.; Ermolaeva S.A.; Galzitskaya O.V.; Optimizing antimicrobial peptide design: Integration of cell-penetrating peptides, amyloidogenic fragments, and amino acid residue modifications. Int J Mol Sci  2024,25(11),6030","journal-title":"Int J Mol Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.3390\/molecules27092675","volume":"27","author":"Li X.","year":"2022","unstructured":"Li X.; Zuo S.; Wang B.; Zhang K.; Wang Y.; Antimicrobial mechanisms and clinical application prospects of antimicrobial peptides. Molecules  2022,27(9),2675","journal-title":"Molecules"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1582863","DOI":"10.3389\/fmicb.2025.1582863","volume":"16","author":"Su Z.","year":"2025","unstructured":"Su Z.; Yu H.; Lv T.; Chen Q.; Luo H.; Zhang H.; Progress in the classification, optimization, activity, and application of antimicrobial peptides. Front Microbiol  2025,16,1582863","journal-title":"Front Microbiol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"111578","DOI":"10.1016\/j.molbiopara.2023.111578","volume":"255","author":"Abbasali Z.","year":"2023","unstructured":"Abbasali Z.; Pirestani M.; Dalimi A.; Badri M.; Fasihi-Ramandi M.; Anti-parasitic activity of a chimeric peptide Cecropin A (2\u22128)-Melittin (6\u22129) (CM11) against tachyzoites of Toxoplasma gondii and the BALB\/c mouse model of acute toxoplasmosis. Mol Biochem Parasitol  2023,255,111578","journal-title":"Mol Biochem Parasitol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s10989-020-10151-2","volume":"27","author":"Eshtiaghi S.","year":"2021","unstructured":"Eshtiaghi S.; Nazari R.; Fasihi-Ramandi M.; In-silico and in-vitro evaluation of antibacterial, cytotoxic, and apoptotic activity and structure of modified CM11 peptide. Int J Pept Res Ther  2021,27(2),1069-1078","journal-title":"Int J Pept Res Ther"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2174\/0929866530666230512142826","volume":"30","author":"Moghaddam M.M.","year":"2023","unstructured":"Moghaddam M.M.; Ebrahimdoust M.; Hayati H.M.; Bahreini M.; A short cationic peptide derived from cecropin and melittin peptides induce apoptosis in jurkat and raji leukemia cell lines. Protein Pept Lett  2023,30(6),477-485","journal-title":"Protein Pept Lett"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11051-020-04838-2","volume":"22","author":"Taghipour-Sabzevar V.","year":"2020","unstructured":"Taghipour-Sabzevar V.; Sharifi T.; Bagheri-Khoulenjani S.; Goodarzi V.; Kooshki H.; Halabian R.; Moghaddam M.; Targeted delivery of a short antimicrobial peptide against CD44-overexpressing tumor cells using hyaluronic acid-coated chitosan nanoparticles: An in vitro study. J Nanopart Res  2020,22(5),99","journal-title":"J Nanopart Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s11274-013-1575-y","volume":"30","author":"Moghaddam M.M.","year":"2014","unstructured":"Moghaddam M.M.; Barjini K.A.; Ramandi M.F.; Amani J.; Investigation of the antibacterial activity of a short cationic peptide against multidrug-resistant Klebsiella pneumoniae and Salmonella typhimurium strains and its cytotoxicity on eukaryotic cells. World J Microbiol Biotechnol  2014,30(5),1533-1540","journal-title":"World J Microbiol Biotechnol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1021\/acsbiomaterials.4c02199","volume":"11","author":"Yang A.","year":"2025","unstructured":"Yang A.; Bai Y.; Zhang Y.; Xiao R.; Zhang H.; Chen F.; Zeng W.; Detection and treatment with peptide power: A new weapon against bacterial biofilms. ACS Biomater Sci Eng  2025,11(2),806-819","journal-title":"ACS Biomater Sci Eng"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1007\/s12602-024-10430-0","volume":"17","author":"Owliaee I.","year":"2025","unstructured":"Owliaee I.; Khaledian M.; Shojaeian A.; Madanchi H.; Yarani R.; Boroujeni A.K.; Shoushtari M.; Antimicrobial peptides against arboviruses: Mechanisms, challenges, and future directions. Probiotics Antimicrob Proteins  2025,17(4),2058-2085","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"15882","DOI":"10.3390\/ijms232415882","volume":"23","author":"Jayathilaka E.H.T.T.","year":"2022","unstructured":"Jayathilaka E.H.T.T.; Nikapitiya C.; De Zoysa M.; Whang I.; Antimicrobial peptide octominin-encapsulated chitosan nanoparticles enhanced antifungal and antibacterial activities. Int J Mol Sci  2022,23(24),15882","journal-title":"Int J Mol Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3390\/md19120697","volume":"19","author":"Hemmingsen L.M.","year":"2021","unstructured":"Hemmingsen L.M.; \u0160kalko-Basnet N.; J\u00f8raholmen M.W.; The expanded role of chitosan in localized antimicrobial therapy. Mar Drugs  2021,19(12),697","journal-title":"Mar Drugs"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10856-023-06748-w","volume":"34","author":"Moosazadeh Moghaddam M.","year":"2023","unstructured":"Moosazadeh Moghaddam M.; Bolouri S.; Golmohammadi R.; Fasihi-Ramandi M.; Heiat M.; Mirnejad R.; Targeted delivery of a short antimicrobial peptide (CM11) against Helicobacter pylori gastric infection using concanavalin A-coated chitosan nanoparticles. J Mater Sci Mater Med  2023,34(9),44","journal-title":"J Mater Sci Mater Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"831655","DOI":"10.3389\/fmicb.2022.831655","volume":"13","author":"Maleki Dizaj S.","year":"2022","unstructured":"Maleki Dizaj S.; Salatin S.; Khezri K.; Lee J.Y.; Lotfipour F.; Targeting multidrug resistance with antimicrobial peptide-decorated nanoparticles and polymers. Front Microbiol  2022,13,831655","journal-title":"Front Microbiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Murray C.J.L.","year":"2022","unstructured":"Murray C.J.L.; Ikuta K.S.; Sharara F.; Swetschinski L.; Robles Aguilar G.; Gray A.; Han C.; Bisignano C.; Rao P.; Wool E.; Johnson S.C.; Browne A.J.; Chipeta M.G.; Fell F.; Hackett S.; Haines-Woodhouse G.; Kashef Hamadani B.H.; Kumaran E.A.P.; McManigal B.; Achalapong S.; Agarwal R.; Akech S.; Albertson S.; Amuasi J.; Andrews J.; Aravkin A.; Ashley E.; Babin F-X.; Bailey F.; Baker S.; Basnyat B.; Bekker A.; Bender R.; Berkley J.A.; Bethou A.; Bielicki J.; Boonkasidecha S.; Bukosia J.; Carvalheiro C.; Casta\u00f1eda-Orjuela C.; Chansamouth V.; Chaurasia S.; Chiurchi\u00f9 S.; Chowdhury F.; Clotaire Donatien R.; Cook A.J.; Cooper B.; Cressey T.R.; Criollo-Mora E.; Cunningham M.; Darboe S.; Day N.P.J.; De Luca M.; Dokova K.; Dramowski A.; Dunachie S.J.; Duong Bich T.; Eckmanns T.; Eibach D.; Emami A.; Feasey N.; Fisher-Pearson N.; Forrest K.; Garcia C.; Garrett D.; Gastmeier P.; Giref A.Z.; Greer R.C.; Gupta V.; Haller S.; Haselbeck A.; Hay S.I.; Holm M.; Hopkins S.; Hsia Y.; Iregbu K.C.; Jacobs J.; Jarovsky D.; Javanmardi F.; Jenney A.W.J.; Khorana M.; Khusuwan S.; Kissoon N.; Kobeissi E.; Kostyanev T.; Krapp F.; Krumkamp R.; Kumar A.; Kyu H.H.; Lim C.; Lim K.; Limmathurotsakul D.; Loftus M.J.; Lunn M.; Ma J.; Manoharan A.; Marks F.; May J.; Mayxay M.; Mturi N.; Munera-Huertas T.; Musicha P.; Musila L.A.; Mussi-Pinhata M.M.; Naidu R.N.; Nakamura T.; Nanavati R.; Nangia S.; Newton P.; Ngoun C.; Novotney A.; Nwakanma D.; Obiero C.W.; Ochoa T.J.; Olivas-Martinez A.; Olliaro P.; Ooko E.; Ortiz-Brizuela E.; Ounchanum P.; Pak G.D.; Paredes J.L.; Peleg A.Y.; Perrone C.; Phe T.; Phommasone K.; Plakkal N.; Ponce-de-Leon A.; Raad M.; Ramdin T.; Rattanavong S.; Riddell A.; Roberts T.; Robotham J.V.; Roca A.; Rosenthal V.D.; Rudd K.E.; Russell N.; Sader H.S.; Saengchan W.; Schnall J.; Scott J.A.G.; Seekaew S.; Sharland M.; Shivamallappa M.; Sifuentes-Osornio J.; Simpson A.J.; Steenkeste N.; Stewardson A.J.; Stoeva T.; Tasak N.; Thaiprakong A.; Thwaites G.; Tigoi C.; Turner C.; Turner P.; van Doorn H.R.; Velaphi S.; Vongpradith A.; Vongsouvath M.; Vu H.; Walsh T.; Walson J.L.; Waner S.; Wangrangsimakul T.; Wannapinij P.; Wozniak T.; Young Sharma T.E.M.W.; Yu K.C.; Zheng P.; Sartorius B.; Lopez A.D.; Stergachis A.; Moore C.; Dolecek C.; Naghavi M.; Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet  2022,399(10325),629-655","journal-title":"Lancet"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"Tacconelli E.","year":"2018","unstructured":"Tacconelli E.; Carrara E.; Savoldi A.; Harbarth S.; Mendelson M.; Monnet D.L.; Pulcini C.; Kahlmeter G.; Kluytmans J.; Carmeli Y.; Ouellette M.; Outterson K.; Patel J.; Cavaleri M.; Cox E.M.; Houchens C.R.; Grayson M.L.; Hansen P.; Singh N.; Theuretzbacher U.; Magrini N.; Aboderin A.O.; Al-Abri S.S.; Awang Jalil N.; Benzonana N.; Bhattacharya S.; Brink A.J.; Burkert F.R.; Cars O.; Cornaglia G.; Dyar O.J.; Friedrich A.W.; Gales A.C.; Gandra S.; Giske C.G.; Goff D.A.; Goossens H.; Gottlieb T.; Guzman Blanco M.; Hryniewicz W.; Kattula D.; Jinks T.; Kanj S.S.; Kerr L.; Kieny M-P.; Kim Y.S.; Kozlov R.S.; Labarca J.; Laxminarayan R.; Leder K.; Leibovici L.; Levy-Hara G.; Littman J.; Malhotra-Kumar S.; Manchanda V.; Moja L.; Ndoye B.; Pan A.; Paterson D.L.; Paul M.; Qiu H.; Ramon-Pardo P.; Rodr\u00edguez-Ba\u00f1o J.; Sanguinetti M.; Sengupta S.; Sharland M.; Si-Mehand M.; Silver L.L.; Song W.; Steinbakk M.; Thomsen J.; Thwaites G.E.; van der Meer J.W.M.; Van Kinh N.; Vega S.; Villegas M.V.; Wechsler-F\u00f6rd\u00f6s A.; Wertheim H.F.L.; Wesangula E.; Woodford N.; Yilmaz F.O.; Zorzet A.; Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis  2018,18(3),318-327","journal-title":"Lancet Infect Dis"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrd3591","volume":"11","author":"Fjell C.D.","year":"2012","unstructured":"Fjell C.D.; Hiss J.A.; Hancock R.E.W.; Schneider G.; Designing antimicrobial peptides: Form follows function. Nat Rev Drug Discov  2012,11(1),37-51","journal-title":"Nat Rev Drug Discov"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fcimb.2016.00194","volume":"6","author":"Mahlapuu M.","year":"2016","unstructured":"Mahlapuu M.; H\u00e5kansson J.; Ringstad L.; Bj\u00f6rn C.; Antimicrobial peptides: An emerging category of therapeutic agents. Front Cell Infect Microbiol  2016,6,194","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.3389\/fmicb.2019.03097","volume":"10","author":"Cardoso M.H.","year":"2020","unstructured":"Cardoso M.H.; Orozco R.Q.; Rezende S.B.; Rodrigues G.; Oshiro K.G.N.; C\u00e2ndido E.S.; Franco O.L.; Computer-aided design of antimicrobial peptides: Are we generating effective drug candidates? Front Microbiol  2020,10,3097","journal-title":"Front Microbiol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/s41467-018-03746-3","volume":"9","author":"Porto W.F.","year":"2018","unstructured":"Porto W.F.; Irazazabal L.; Alves E.S.F.; Ribeiro S.M.; Matos C.O.; Pires \u00c1.S.; Fensterseifer I.C.M.; Miranda V.J.; Haney E.F.; Humblot V.; Torres M.D.T.; Hancock R.E.W.; Liao L.M.; Ladram A.; Lu T.K.; de la Fuente-Nunez C.; Franco O.L.; In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design. Nat Commun  2018,9(1),1490","journal-title":"Nat Commun"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3389\/fmicb.2020.01767","volume":"11","author":"Shang L.","year":"2020","unstructured":"Shang L.; Li J.; Song C.; Nina Z.; Li Q.; Chou S.; Wang Z.; Shan A.; Hybrid antimicrobial peptide targeting Staphylococcus aureus and displaying anti-infective activity in a murine model. Front Microbiol  2020,11,1767","journal-title":"Front Microbiol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.biomaterials.2012.09.032","volume":"34","author":"Liu Y.","year":"2013","unstructured":"Liu Y.; Xia X.; Xu L.; Wang Y.; Design of hybrid \u03b2-hairpin peptides with enhanced cell specificity and potent anti-inflammatory activity. Biomaterials  2013,34(1),237-250","journal-title":"Biomaterials"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"12316","DOI":"10.1074\/jbc.M413406200","volume":"280","author":"Chen Y.","year":"2005","unstructured":"Chen Y.; Mant C.T.; Farmer S.W.; Hancock R.E.W.; Vasil M.L.; Hodges R.S.; Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity\/therapeutic index. J Biol Chem  2005,280(13),12316-12329","journal-title":"J Biol Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.2174\/0113816128248959231102114334","volume":"29","author":"Sharma L.","year":"2023","unstructured":"Sharma L.; Bisht G.S.; Short antimicrobial peptides: Therapeutic potential and recent advancements. Curr Pharm Des  2023,29(38),3005-3017","journal-title":"Curr Pharm Des"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1124\/pr.55.1.2","volume":"55","author":"Yeaman M.R.","year":"2003","unstructured":"Yeaman M.R.; Yount N.Y.; Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev  2003,55(1),27-55","journal-title":"Pharmacol Rev"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"7387","DOI":"10.3390\/ijms26157387","volume":"26","author":"Ying F.","year":"2025","unstructured":"Ying F.; Go W.; Li Z.; Ouyang C.; Phaphuangwittayakul A.; Dhuny R.; Computational design of potentially multifunctional antimicrobial peptide candidates via a hybrid generative model. Int J Mol Sci  2025,26(15),7387","journal-title":"Int J Mol Sci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.bbamem.2008.09.013","volume":"1788","author":"Matsuzaki K.","year":"2009","unstructured":"Matsuzaki K.; Control of cell selectivity of antimicrobial peptides. Biochim Biophys Acta Biomembr  2009,1788(8),1687-1692","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1128\/AAC.00925-06","volume":"51","author":"Chen Y.","year":"2007","unstructured":"Chen Y.; Guarnieri M.T.; Vasil A.I.; Vasil M.L.; Mant C.T.; Hodges R.S.; Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Antimicrob Agents Chemother  2007,51(4),1398-1406","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/1097-0282(2000)55:1<4:AID-BIP30>3.0.CO;2-M","volume":"55","author":"Tossi A.","year":"2000","unstructured":"Tossi A.; Sandri L.; Giangaspero A.; Amphipathic, \u03b1-helical antimicrobial peptides. Biopolymers  2000,55(1),4-30","journal-title":"Biopolymers"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.peptides.2011.02.017","volume":"32","author":"Molhoek E.M.","year":"2011","unstructured":"Molhoek E.M.; van Dijk A.; Veldhuizen E.J.A.; Haagsman H.P.; Bikker F.J.; Improved proteolytic stability of chicken cathelicidin-2 derived peptides by d-amino acid substitutions and cyclization. Peptides  2011,32(5),875-880","journal-title":"Peptides"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"8498","DOI":"10.1021\/acs.jmedchem.3c00140","volume":"66","author":"Selvarajan V.","year":"2023","unstructured":"Selvarajan V.; Tram N.D.T.; Xu J.; Ngen S.T.Y.; Koh J.J.; Teo J.W.P.; Yuen T.Y.; Ee P.L.R.; Stapled \u03b2-hairpin antimicrobial peptides with improved stability and activity against drug-resistant gram-negative bacteria. J Med Chem  2023,66(13),8498-8509","journal-title":"J Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"9728","DOI":"10.1021\/acsomega.4c11466","volume":"10","author":"Mitra S.","year":"2025","unstructured":"Mitra S.; Chen M.T.; Stedman F.; Hernandez J.; Kumble G.; Kang X.; Zhang C.; Tang G.; Reed I.; Daugherty I.Q.; Liu W.; Klucznik K.R.; Ocloo J.L.; Li A.A.; Klousnitzer J.; Heinrich F.; Deslouches B.; Tristram-Nagle S.; Cyclization of two antimicrobial peptides improves their activity. ACS Omega  2025,10(9),9728-9740","journal-title":"ACS Omega"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4062\/biomolther.2012.20.1.019","volume":"20","author":"Joo S.H.","year":"2012","unstructured":"Joo S.H.; Cyclic peptides as therapeutic agents and biochemical tools. Biomol Ther  2012,20(1),19-26","journal-title":"Biomol Ther"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/978-981-97-7316-9_11","author":"Akojwar N.","year":"2025","unstructured":"Akojwar N.; Mishra A.; Mishra P.; Tekade M.; Mule S.; Tekade R.; PEGylation of therapeutic proteins and peptides. PEGylated Nanocarriers in Medicine and Pharmacy  2025,317-343","journal-title":"PEGylated Nanocarriers in Medicine and Pharmacy"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.2147\/DDDT.S147450","volume":"11","author":"Almaaytah A.","year":"2017","unstructured":"Almaaytah A.; Mohammed G.; Abualhaijaa A.; Al-Balas Q.; Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria. Drug Des Devel Ther  2017,11,3159-3170","journal-title":"Drug Des Devel Ther"},{"key":"ref=40","first-page":"3919","volume":"11","author":"Lei J.","year":"2019","unstructured":"Lei J.; Sun L.; Huang S.; Zhu C.; Li P.; He J.; Mackey V.; Coy D.H.; He Q.; The antimicrobial peptides and their potential clinical applications. Am J Transl Res  2019,11(7),3919-3931","journal-title":"Am J Transl Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fmicb.2013.00294","volume":"4","author":"Gaspar D.","year":"2013","unstructured":"Gaspar D.; Veiga A.S.; Castanho M.A.R.B.; From antimicrobial to anticancer peptides. A review. Front Microbiol  2013,4,294","journal-title":"Front Microbiol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"101012","DOI":"10.1016\/j.drup.2023.101012","volume":"71","author":"de la Fuente-Nunez C.","year":"2023","unstructured":"de la Fuente-Nunez C.; Cesaro A.; Hancock R.E.W.; Antibiotic failure: Beyond antimicrobial resistance. Drug Resist Updat  2023,71,101012","journal-title":"Drug Resist Updat"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jiac.2015.02.001","volume":"21","author":"As\u00edn-Prieto E.","year":"2015","unstructured":"As\u00edn-Prieto E.; Rodr\u00edguez-Gasc\u00f3n A.; Isla A.; Applications of the pharmacokinetic\/pharmacodynamic (PK\/PD) analysis of antimicrobial agents. J Infect Chemother  2015,21(5),319-329","journal-title":"J Infect Chemother"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"eaau5480","DOI":"10.1126\/science.aau5480","volume":"368","author":"Lazzaro B.P.","year":"2020","unstructured":"Lazzaro B.P.; Zasloff M.; Rolff J.; Antimicrobial peptides: Application informed by evolution. Science  2020,368(6490),eaau5480","journal-title":"Science"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"13002","DOI":"10.1038\/ncomms13002","volume":"7","author":"Jochumsen N.","year":"2016","unstructured":"Jochumsen N.; Marvig R.L.; Damki\u00e6r S.; Jensen R.L.; Paulander W.; Molin S.; Jelsbak L.; Folkesson A.; The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactions. Nat Commun  2016,7(1),13002","journal-title":"Nat Commun"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"940","DOI":"10.2174\/0929866522666150728115439","volume":"22","author":"Amani J.","year":"2015","unstructured":"Amani J.; Barjini K.; Moghaddam M.; Asadi A.; In vitro synergistic effect of the CM11 antimicrobial peptide in combination with common antibiotics against clinical isolates of six species of multidrug-resistant pathogenic bacteria. Protein Pept Lett  2015,22(10),940-951","journal-title":"Protein Pept Lett"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.3390\/ijms21197047","volume":"21","author":"Browne K.","year":"2020","unstructured":"Browne K.; Chakraborty S.; Chen R.; Willcox M.D.P.; Black D.S.; Walsh W.R.; Kumar N.; A new era of antibiotics: The clinical potential of antimicrobial peptides. Int J Mol Sci  2020,21(19),7047","journal-title":"Int J Mol Sci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00726-024-03438-x","volume":"57","author":"Rahmani D.","year":"2025","unstructured":"Rahmani D.; Taheri R.A.; Moosazadeh Moghaddam M.; Targeted delivery of curcumin and CM11 peptide against hepatocellular carcinoma cells based on binding affinity of PreS1-coated chitosan nanoparticles to SB3 protein. Amino Acids  2025,57(1),12","journal-title":"Amino Acids"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1039\/D3NH00173C","volume":"8","author":"Fan P.","year":"2023","unstructured":"Fan P.; Guan Y.; Zhang X.; Wang J.; Xu Y.; Song B.; Zhang S.; Wang H.; Liu Y.; Qiao Z.Y.; Cell membrane-specific self-assembly of peptide nanomedicine induces tumor immunogenic death to enhance cancer therapy. Nanoscale Horiz  2023,8(9),1226-1234","journal-title":"Nanoscale Horiz"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s10989-020-10126-3","volume":"27","author":"Aghamollaei H.","year":"2021","unstructured":"Aghamollaei H.; Safabakhsh H.; Moosazadeh M.M.; Zare H.; Bakherad H.; Jadidi K.; Evaluation of a cationic antimicrobial peptide as the new antibiotic candidate to treat Staphylococcus aureus keratitis. Int J Pept Res Ther  2021,27(1),755-762","journal-title":"Int J Pept Res Ther"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"16723","DOI":"10.3390\/ijms242316723","volume":"24","author":"Kravchenko S.V.","year":"2023","unstructured":"Kravchenko S.V.; Domnin P.A.; Grishin S.Y.; Vershinin N.A.; Gurina E.V.; Zakharova A.A.; Azev V.N.; Mustaeva L.G.; Gorbunova E.Y.; Kobyakova M.I.; Surin A.K.; Fadeev R.S.; Ostroumova O.S.; Ermolaeva S.A.; Galzitskaya O.V.; Enhancing the antimicrobial properties of peptides through cell-penetrating peptide conjugation: A comprehensive assessment. Int J Mol Sci  2023,24(23),16723","journal-title":"Int J Mol Sci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrmicro1098","volume":"3","author":"Brogden K.A.","year":"2005","unstructured":"Brogden K.A.; Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol  2005,3(3),238-250","journal-title":"Nat Rev Microbiol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0005-2736(99)00197-2","volume":"1462","author":"Matsuzaki K.","year":"1999","unstructured":"Matsuzaki K.; Why and how are peptide\u2013lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta Biomembr  1999,1462(1-2),1-10","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12602-012-9098-7","volume":"4","author":"Moghaddam M.M.","year":"2012","unstructured":"Moghaddam M.M.; Abolhassani F.; Babavalian H.; Mirnejad R.; Azizi Barjini K.; Amani J.; Comparison of in vitro antibacterial activities of two cationic peptides CM15 and CM11 against five pathogenic bacteria: Pseudomonas aeruginosa, Staphylococcus aureus, Vibrio cholerae, Acinetobacter baumannii, and Escherichia coli. Probiotics Antimicrob Proteins  2012,4(2),133-139","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/20415990.2024.2369497","volume":"15","author":"Bahreini M.","year":"2024","unstructured":"Bahreini M.; Moghaddam M.M.; Ghorbani M.; Nourani M.R.; Mirnejad R.; Antimicrobial peptide-fibrin glue mixture for treatment of methicillin-resistant Staphylococcus aureus -infected wounds. Ther Deliv  2024,15(8),577-591","journal-title":"Ther Deliv"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s00726-018-2638-z","volume":"50","author":"Moosazadeh M.M.","year":"2018","unstructured":"Moosazadeh M.M.; Eftekhary M.; Erfanimanesh S.; Hashemi A.; Fallah Omrani V.; Farhadihosseinabadi B.; Lasjerdi Z.; Mossahebi-Mohammadi M.; Pal S.C.N.; Seifalian A.M.; Gholipourmalekabadi M.; Comparison of the antibacterial effects of a short cationic peptide and 1% silver bioactive glass against extensively drug-resistant bacteria, Pseudomonas aeruginosa and Acinetobacter baumannii, isolated from burn patients. Amino Acids  2018,50(11),1617-1628","journal-title":"Amino Acids"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.fsi.2021.09.035","volume":"119","author":"Rashidian G.","year":"2021","unstructured":"Rashidian G.; Moosazadeh Moghaddam M.; Mirnejad R.; Mohammadi Azad Z.; Supplementation of zebrafish (Danio rerio) diet using a short antimicrobial peptide: Evaluation of growth performance, immunomodulatory function, antioxidant activity, and disease resistance. Fish Shellfish Immunol  2021,119,42-50","journal-title":"Fish Shellfish Immunol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"28320","DOI":"10.5812\/jjm.28320","volume":"8","author":"Babavalian H.","year":"2015","unstructured":"Babavalian H.; Latifi A.M.; Shokrgozar M.A.; Bonakdar S.; Mohammadi S.; Moosazadeh Moghaddam M.; Analysis of healing effect of alginate sulfate hydrogel dressing containing antimicrobial peptide on wound infection caused by methicillin-resistant Staphylococcus aureus. Jundishapur J Microbiol  2015,8(9),28320","journal-title":"Jundishapur J Microbiol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/life15020242","volume":"15","author":"Kocagoz T.","year":"2025","unstructured":"Kocagoz T.; Temur B.Z.; Unubol N.; Acikel Elmas M.; Kanlidere Z.; Cilingir S.; Acar D.; Boskan G.; Akcelik Deveci S.; Aybakan E.; Ozcan Yoner A.; Yurttutan Uyar N.; Serteser M.; Sahsuvar S.; Erdemgil Y.; Yildirim Keles Z.Z.; Demirhan D.; Sakalauskaite S.; Daugelavicius R.; Ozal Ildeniz T.A.; Atik A.E.; Mozioglu E.; Eren T.; Arbak S.; Suyen G.; Can O.; Protease-resistant, broad-spectrum antimicrobial peptides with high antibacterial and antifungal activity. Life  2025,15(2),242","journal-title":"Life"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"e00265","DOI":"10.1128\/spectrum.00265-24","volume":"12","author":"Zhang C.","year":"2024","unstructured":"Zhang C.; Fu L.; Zhu Y.; Chen Q.; Chen Z.; Chang Y.F.; Li Y.; Yao M.; Huang X.; Jin L.; Gao X.; Zhang Y.; Jin B.; Chou S.; Luo L.; Antimicrobial activity of novel symmetrical antimicrobial peptides centered on a hydrophilic motif against resistant clinical isolates: In vitro and in vivo analyses. Microbiol Spectr  2024,12(11),e00265-e24","journal-title":"Microbiol Spectr"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0732-8893(00)00175-9","volume":"38","author":"Giacometti A.","year":"2000","unstructured":"Giacometti A.; Cirioni O.; Barchiesi F.; Scalise G.; In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics. Diagn Microbiol Infect Dis  2000,38(2),115-118","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1128\/AAC.35.6.1153","volume":"35","author":"Darveau R.P.","year":"1991","unstructured":"Darveau R.P.; Cunningham M.D.; Seachord C.L.; Cassiano-Clough L.; Cosand W.L.; Blake J.; Watkins C.S.; Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo. Antimicrob Agents Chemother  1991,35(6),1153-1159","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3390\/ph17111555","volume":"17","author":"Hetta H.F.","year":"2024","unstructured":"Hetta H.F.; Sirag N.; Alsharif S.M.; Alharbi A.A.; Alkindy T.T.; Alkhamali A.; Albalawi A.S.; Ramadan Y.N.; Rashed Z.I.; Alanazi F.E.; Antimicrobial peptides: The game-changer in the epic battle against multidrug-resistant bacteria. Pharmaceuticals  2024,17(11),1555","journal-title":"Pharmaceuticals"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1099\/jmm.0.000524","volume":"66","author":"Mohammadi A.Z.","year":"2017","unstructured":"Mohammadi A.Z.; Moravej H.; Fasihi-Ramandi M.; Masjedian F.; Nazari R.; Mirnejad R.; Moosazadeh M.M.; In vitro synergistic effects of a short cationic peptide and clinically used antibiotics against drug-resistant isolates of Brucella melitensis. J Med Microbiol  2017,66(7),919-926","journal-title":"J Med Microbiol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1111\/iwj.14215","volume":"20","author":"Moosazadeh Moghaddam M.","year":"2023","unstructured":"Moosazadeh Moghaddam M.; Farhadie B.; Mirnejad R.; Kooshki H.; Evaluation of an antibacterial peptide\u2010loaded amniotic membrane\/silk fibroin electrospun nanofiber in wound healing. Int Wound J  2023,20(9),3443-3456","journal-title":"Int Wound J"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00508-019-01540-9","volume":"131","author":"Mahdavi Abhari F.","year":"2019","unstructured":"Mahdavi Abhari F.; Pirestani M.; Dalimi A.; Anti-amoebic activity of a cecropin-melittin hybrid peptide (CM11) against trophozoites of Entamoeba histolytica. Wien Klin Wochenschr  2019,131(17-18),427-434","journal-title":"Wien Klin Wochenschr"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"413","DOI":"10.22092\/ari.2018.122300.1222","volume":"74","author":"Aqeele G.","year":"2019","unstructured":"Aqeele G.; Shayan P.; Ebrahimzadeh E.; Mohebali M.; Khalili S.; Determination of the effective dose of curcumin alone and in combination with antimicrobial peptide CM11 on promastigote forms of iranian strain of L. major (MRHO\/IR\/75\/ER). Arch Razi Inst  2019,74(4),413-422","journal-title":"Arch Razi Inst"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"108151","DOI":"10.1016\/j.exppara.2021.108151","volume":"229","author":"Aqeele G.","year":"2021","unstructured":"Aqeele G.; Shayan P.; Ebrahimzade A.E.; Mohebali M.; Evaluation of curcumin and CM11 peptide alone and in combination against amastigote form of Iranian strain of L. major (MRHO\/IR75\/ER) in vitro. Exp Parasitol  2021,229,108151","journal-title":"Exp Parasitol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"105384","DOI":"10.1016\/j.actatropica.2020.105384","volume":"204","author":"Kordestani Shargh E.","year":"2020","unstructured":"Kordestani Shargh E.; Pirestani M.; Sadraei J.; In vitro toxicity evaluation of short cationic antimicrobial peptide (CM11) on Blastocystis sp. Acta Trop  2020,204,105384","journal-title":"Acta Trop"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"2206602","DOI":"10.1002\/advs.202206602","volume":"10","author":"Li G.","year":"2023","unstructured":"Li G.; Lai Z.; Shan A.; Advances of antimicrobial peptide\u2010based biomaterials for the treatment of bacterial infections. Adv Sci  2023,10(11),2206602","journal-title":"Adv Sci"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00726-023-03277-2","volume":"55","author":"Ghasemi H.H.","year":"2023","unstructured":"Ghasemi H.H.; Alizadeh S.; Mahboobi L.; Khosrowpour Z.; Nazm Bojnordi M.; Aliakbar Ahovan Z.; Malekzadeh Shafaroudi M.; Zahiri M.; Chauhan N.P.S.; Gholipourmalekabadi M.; Antimicrobial peptide-loaded decellularized placental sponge as an excellent antibacterial skin substitute against XDR clinical isolates. Amino Acids  2023,55(8),955-967","journal-title":"Amino Acids"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"8291","DOI":"10.24294\/can8291","volume":"8","author":"Monika N.","year":"2024","unstructured":"Monika N.; Sirisha N.; Nawale S.; Polymeric nanoparticles for protein and peptide delivery. Char and Appl of Nanomaterials  2024,8(1),8291","journal-title":"Char and Appl of Nanomaterials"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2174\/0113895575362479241231054240","volume":"25","author":"Noordin M.A.M.","year":"2025","unstructured":"Noordin M.A.M.; Najm A.A.; Dyari H.R.E.; Law D.; Alwi S.S.S.; Lazim A.M.; Cheah Y.H.; Tee T.T.; Fazry S.; In vivo pharmacokinetic and ADMET profiles of synthetic antimicrobial peptides (AMPs). Mini Rev Med Chem  2025,25(8),579-590","journal-title":"Mini Rev Med Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"323","DOI":"10.30466\/vrf.2018.33107","volume":"9","author":"Khalili S.","year":"2018","unstructured":"Khalili S.; Mohebali M.; Ebrahimzadeh E.; Shayan E.; Mohammadi-Yeganeh S.; Moosazadeh Moghaddam M.; Elikaee S.; Akhoundi B.; Sharifi-Yazdi M.K.; Antimicrobial activity of an antimicrobial peptide against amastigote forms of Leishmania major. Vet Res Forum  2018,9(4),323-328","journal-title":"Vet Res Forum"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1528583","DOI":"10.3389\/fcimb.2025.1528583","volume":"15","author":"Sadeeq M.","year":"2025","unstructured":"Sadeeq M.; Li Y.; Wang C.; Hou F.; Zuo J.; Xiong P.; Unlocking the power of antimicrobial peptides: Advances in production, optimization, and therapeutics. Front Cell Infect Microbiol  2025,15,1528583","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.3390\/molecules27144584","volume":"27","author":"Bellotti D.","year":"2022","unstructured":"Bellotti D.; Remelli M.; Lights and shadows on the therapeutic use of antimicrobial peptides. Molecules  2022,27(14),4584","journal-title":"Molecules"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1425952","DOI":"10.3389\/fmicb.2024.1425952","volume":"15","author":"Ma X.","year":"2024","unstructured":"Ma X.; Aminov R.; Franco O.L.; de la Fuente-Nunez C.; Wang G.; Wang J.; Editorial: Antimicrobial peptides and their druggability, bio-safety, stability, and resistance. Front Microbiol  2024,15,1425952","journal-title":"Front Microbiol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/antibiotics11030349","volume":"11","author":"Zhang C.","year":"2022","unstructured":"Zhang C.; Yang M.; Antimicrobial peptides: From design to clinical application. Antibiotics  2022,11(3),349","journal-title":"Antibiotics"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12967-025-06321-9","volume":"23","author":"Zheng S.","year":"2025","unstructured":"Zheng S.; Tu Y.; Li B.; Qu G.; Li A.; Peng X.; Li S.; Shao C.; Antimicrobial peptide biological activity, delivery systems and clinical translation status and challenges. J Transl Med  2025,23(1),292","journal-title":"J Transl Med"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"9031","DOI":"10.3390\/ijms24109031","volume":"24","author":"Mazurkiewicz-Pisarek A.","year":"2023","unstructured":"Mazurkiewicz-Pisarek A.; Baran J.; Ciach T.; Antimicrobial peptides: Challenging journey to the pharmaceutical, biomedical, and cosmeceutical use. Int J Mol Sci  2023,24(10),9031","journal-title":"Int J Mol Sci"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"10821","DOI":"10.3390\/ijms251910821","volume":"25","author":"Gagat P.","year":"2024","unstructured":"Gagat P.; Ostr\u00f3wka M.; Duda-Madej A.; Mackiewicz P.; Enhancing antimicrobial peptide activity through modifications of charge, hydrophobicity, and structure. Int J Mol Sci  2024,25(19),10821","journal-title":"Int J Mol Sci"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665449691260331114022","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/252988\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665449691260331114022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:53:24Z","timestamp":1778759604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/252988\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298665449691260331114022","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-09-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}